<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>w57038e10-k.htm
<DESCRIPTION>FORM 10-K E. I. DU PONT DE NEMOURS AND COMPANY
<TEXT>
<HTML>
<HEAD>
<TITLE>e10-k</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV align="center">
<B><FONT size="5">2001</FONT></B>
</DIV>

<P align="left">
<HR size="1" width="100%" align="left" noshade>

<DIV align="left">
<HR size="1" width="100%" align="left" noshade>
</DIV>

<P align="center">
<B><FONT size="5">UNITED STATES</FONT></B>

<DIV align="center">
<B><FONT size="5">SECURITIES AND EXCHANGE COMMISSION</FONT></B>
</DIV>

<DIV align="center">
<B><FONT size="4">WASHINGTON, D.C. 20549</FONT></B>
</DIV>

<P align="center">
<B><FONT size="5">FORM&nbsp;10-K</FONT></B>

<P align="center">
<B>Annual Report Pursuant to Section 13 or 15(d) of</B>

<DIV align="center">
<B>the Securities Exchange Act of 1934</B>
</DIV>

<DIV>&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="50%"></TD>
	<TD width="50%"></TD>
</TR>

<TR valign="top">
	<TD align="left"><B><FONT size="2">For the year ended December&nbsp;31,&nbsp;2001</FONT></B></TD>
	<TD align="right"><B><FONT size="2">Commission file number 1-815</FONT></B></TD>
</TR>

</TABLE>

<P align="center">
<HR size="1" width="30%" align="center" noshade>

<P align="center">
<B><FONT size="6">E. I. DU PONT DE NEMOURS</FONT></B>

<DIV align="center">
<B><FONT size="6">AND COMPANY</FONT></B>
</DIV>

<DIV align="center">
<B><FONT size="2">(Exact name of registrant as specified in its
charter)</FONT></B>
</DIV>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="52%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="45%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD align="center" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<B><FONT size="2">DELAWARE</FONT></B></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">51-0014090</FONT></B></TD>
</TR>

<TR>
	<TD align="center" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<B><FONT size="2">(State or Other Jurisdiction of Incorporation
	or Organization)</FONT></B></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">(I.R.S. Employer Identification No.)</FONT></B></TD>
</TR>

</TABLE>
</CENTER>

<P align="center">
<B><FONT size="2">1007 Market Street</FONT></B>

<DIV align="center">
<B><FONT size="2">Wilmington, Delaware 19898</FONT></B>
</DIV>

<DIV align="center">
<B><FONT size="2">(Address of principal executive
offices)</FONT></B>
</DIV>

<P align="center">
<B><FONT size="2">Registrant&#146;s telephone number, including
area code: 302&nbsp;774-1000</FONT></B>

<DIV align="center">
<B><FONT size="2">Securities registered pursuant to
Section&nbsp;12(b) of the Act</FONT></B>
</DIV>

<DIV align="center">
<B><FONT size="2">(Each class is registered on the New York
Stock Exchange, Inc.):</FONT></B>
</DIV>

<P align="center">
<B><FONT size="2">Title of Each Class</FONT></B>

<DIV align="center">
<HR size="1" width="26%" align="center" noshade>
</DIV>

<DIV align="center">
<FONT size="2">Common Stock ($.30 par value)
</FONT>
</DIV>

<DIV align="center">
<FONT size="2">Preferred Stock
</FONT>
</DIV>

<DIV align="center">
<FONT size="2">(without par value-cumulative)
</FONT>
</DIV>

<DIV align="center">
<FONT size="2">$4.50 Series
</FONT>
</DIV>

<DIV align="center">
<FONT size="2">$3.50 Series
</FONT>
</DIV>

<P align="center">
<B><FONT size="2">No securities are registered pursuant to
Section&nbsp;12(g) of the Act.</FONT></B>

<P align="center">
<HR size="1" width="30%" align="center" noshade>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">Indicate by check mark if disclosure of
delinquent filers pursuant to Item&nbsp;405 of
Regulation&nbsp;S-K is not contained herein, and will not be
contained, to the best of registrant&#146;s knowledge, in
definitive proxy or information statements incorporated by
reference in Part III of this Form&nbsp;10-K or any amendment to
this
Form&nbsp;10-K.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="wingdings">&#111;</FONT></FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">Indicate by check mark whether the registrant
(1)&nbsp;has filed all reports required to be filed by
Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12&nbsp;months (or for such shorter period
that the registrant was required to file such reports), and
(2)&nbsp;has been subject to such filing requirements for the
past
90&nbsp;days.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;<FONT face="wingdings">&#254;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;<FONT face="wingdings">&#111;</FONT></FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">Aggregate market value of voting stock held by
nonaffiliates of the registrant (excludes outstanding shares
beneficially owned by directors and officers and treasury
shares) as of March&nbsp;7, 2002, was approximately
$46.6&nbsp;billion. As of such date, 992,953,510 shares
(excludes 87,041,427 shares of treasury stock) of the
company&#146;s common stock, $.30 par value, were
outstanding.</FONT></B>

<P align="center">
<B><FONT size="2">Documents Incorporated by Reference</FONT></B>

<DIV align="center">
<B><FONT size="2">(Specific pages incorporated are indicated
under the applicable Item herein):</FONT></B>
</DIV>

<CENTER>
<TABLE width="70%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="80%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="8%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="8%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">Incorporated</FONT></B></TD>
</TR>

<TR>
	<TD></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">By Reference</FONT></B></TD>
</TR>

<TR>
	<TD></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">In Part No.</FONT></B></TD>
</TR>

<TR>
	<TD></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">The company&#146;s 2001 Annual Report to
	Stockholders
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="bottom" nowrap><FONT size="2">I, II, and IV</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">The company&#146;s Proxy Statement, dated
	March&nbsp;21, 2002, in connection with the Annual Meeting of
	Stockholders to be held on April&nbsp;24, 2002
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">III</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<P align="left">
<HR size="1" width="100%" align="left" noshade>

<DIV align="left">
<HR size="1" width="100%" align="left" noshade>
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD colspan="9"><A HREF="#000">PART I</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#001">Item 1. BUSINESS</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#002">Item 2. PROPERTIES</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#003">Item 3. LEGAL PROCEEDINGS</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#004">Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS</A></TD></TR>
<TR><TD colspan="9"><A HREF="#005">PART II</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#006">Item 5. MARKET FOR REGISTRANT&#146;S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#007">Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</A></TD></TR>
<TR><TD colspan="9"><A HREF="#008">PART III</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#009">Item 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#010">Item 11. EXECUTIVE COMPENSATION</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#011">Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#012">Item 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K</A></TD></TR>
<TR><TD colspan="9"><A HREF="#013">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="w57038e10-k.htm">FORM 10-K E. I. DU PONT DE NEMOURS AND COMPANY</A></TD></TR>
<TR><TD colspan="9"><A HREF="w57038ex10-3.txt">COMPANY'S SUPPLEMENTAL RETIREMENT INCOME PLAN</A></TD></TR>
<TR><TD colspan="9"><A HREF="w57038ex10-4.txt">COMPANY'S PENSION RESTORATION PLAN</A></TD></TR>
<TR><TD colspan="9"><A HREF="w57038ex10-9.txt">COMPANY'S 1997 CORPORATE SHARING PLAN</A></TD></TR>
<TR><TD colspan="9"><A HREF="w57038ex11.txt">STATEMENT RE CALCULATION OF EARNINGS PER SHARE</A></TD></TR>
<TR><TD colspan="9"><A HREF="w57038ex12.txt">STATEMENT RE COMPUTATION OF THE RATIO OF EARNINGS</A></TD></TR>
<TR><TD colspan="9"><A HREF="w57038ex13.txt">MANAGEMENT'S DISCUSSION AND ANALYSIS</A></TD></TR>
<TR><TD colspan="9"><A HREF="w57038ex21.txt">SUBSIDIARIES OF THE REGISTRANT</A></TD></TR>
<TR><TD colspan="9"><A HREF="w57038ex23.txt">CONSENT OF INDEPENDENT ACCOUNTANTS</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="center">
<B><FONT size="2">E. I. DU PONT DE NEMOURS AND COMPANY</FONT></B>

<P align="center">
<HR size="1" width="30%" align="center" noshade>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The terms &#147;DuPont&#148; or the
&#147;company&#148; as used herein refer to E. I. du Pont de
Nemours and Company and its consolidated subsidiaries (which are
wholly owned or majority-owned), or to E. I. du Pont de Nemours
and Company, as the context may indicate.
</FONT>

<P align="center">
<HR size="1" width="30%" align="center" noshade>

<P align="center">
<B>TABLE OF CONTENTS</B>

<CENTER>
<TABLE width="80%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="10%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="72%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="2"></TD>
	<TD></TD>
	<TD></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">Page(s)</FONT></B></TD>
</TR>

<TR>
	<TD colspan="2"></TD>
	<TD></TD>
	<TD></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<B><FONT size="2">Part I</FONT></B></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;1.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Business
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">3-9</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;2.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Properties
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">9</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;3.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Legal Proceedings
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">10-11</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;4.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Submission of Matters to a Vote of Security
	Holders
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">11</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="2"><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Executive Officers of the Registrant
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">12</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="8"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<B><FONT size="2">Part II</FONT></B></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;5.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Market for Registrant&#146;s Common Equity and
	Related Stockholder Matters
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">13</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;6.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Selected Financial Data
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">13</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;7.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Management&#146;s Discussion and Analysis of
	Financial Condition and Results of<BR>
	Operations
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">13-14</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;7A.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Quantitative and Qualitative Disclosures About
	Market Risk
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">14</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;8.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Financial Statements and Supplementary Data
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">15</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;9.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Changes In and Disagreements With Accountants on
	Accounting and Financial Disclosure
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">15</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="8"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<B><FONT size="2">Part III</FONT></B></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;10.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Directors and Executive Officers of the Registrant
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">15</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;11.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Executive Compensation
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">15</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;12.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Security Ownership of Certain Beneficial Owners
	and Management
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">15</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;13.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Certain Relationships and Related Transactions
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">15</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="8"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<B><FONT size="2">Part IV</FONT></B></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Item&nbsp;14.
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="bottom">
	<FONT size="2">Exhibits, Financial Statement Schedules, and
	Reports on Form&nbsp;8-K
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">16-17</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="4" align="left" valign="top">
	<FONT size="2">Signatures
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">18</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<P align="center">
<B>Note on Incorporation by Reference</B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Throughout this report, various information and
data are incorporated by reference to portions of the
company&#146;s 2001 Annual Report to Stockholders (those
portions are hereinafter referred to as Exhibit&nbsp;13). Any
reference in this report to disclosures in Exhibit&nbsp;13 shall
constitute incorporation by reference of that specific material
into this Form&nbsp;10-K.
</FONT>

<P align="center"><FONT size="2">2
</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<!-- link1 "PART I" -->
<DIV align="left"><A NAME="000"></A></DIV>

<P align="center">
<B>PART I</B>

<!-- link2 "Item 1. BUSINESS" -->
<DIV align="left"><A NAME="001"></A></DIV>

<P align="left">
<B><FONT size="2">Item&nbsp;1.&nbsp;&nbsp;BUSINESS</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">DuPont was founded in 1802 and was incorporated
in Delaware in 1915. DuPont is a world leader in science and
technology in a range of disciplines including high-performance
materials, synthetic fibers, electronics, specialty chemicals,
agriculture and biotechnology. The company operates globally
through some 22 strategic business units. Within the strategic
business units, a wide range of products are manufactured for
distribution and sale to many different markets, including the
transportation, textile, construction, motor vehicle,
agricultural, home furnishings, medical, packaging, electronics
and the nutrition and health markets.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company&#146;s strategic business units are
aggregated into eight reportable segments&nbsp;&#150;
Agriculture &#38; Nutrition, Nylon, Performance Coatings &#38;
Polymers, Pharmaceuticals, Pigments &#38; Chemicals, Polyester,
Specialty Fibers, and Specialty Polymers. The following pages,
including those pages of Exhibit&nbsp;13 specifically
incorporated herein, provide perspective on these eight
segments. The company&#146;s nonaligned businesses and embryonic
businesses are grouped under &#147;Other.&#148; These businesses
represent approximately 1&nbsp;percent of total 2001 segment
sales and are discussed on page&nbsp;29 of Exhibit&nbsp;13.
Financial data for the segments is provided in Note&nbsp;32,
&#147;Segment Information,&#148; on pages&nbsp;71
through&nbsp;74 of Exhibit&nbsp;13.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company and its subsidiaries have operations
in about 75 countries worldwide and, as a result, about
50&nbsp;percent of consolidated sales are made to customers
outside the United States. Subsidiaries and affiliates of DuPont
conduct manufacturing, seed production, or selling activities,
and some are distributors of products manufactured by the
company. Total worldwide employment at year-end 2001 was about
79,000 people.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In February&nbsp;2002, the company announced the
realignment of its businesses into five market- and
technology-focused growth platforms and its plans for the
creation of a Textiles and Interiors subsidiary. The growth
platforms are: DuPont Electronic &#38; Communication
Technologies; DuPont Performance Materials; DuPont Coatings
&#38; Color Technologies; DuPont Safety &#38; Protection; and
DuPont Agriculture &#38; Nutrition. DuPont will consider a full
range of options to separate DuPont Textiles &#38; Interiors
from the company by year-end 2003, market conditions permitting.
The disclosures contained in this report and incorporated by
reference to Exhibit&nbsp;13 reflect the company&#146;s
organizational structure that existed at December&nbsp;31, 2001.
</FONT>

<P align="left">
<B><FONT size="2">Sale of DuPont Pharmaceuticals</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">On October&nbsp;1, 2001, DuPont Pharmaceuticals
was sold to the Bristol-Myers Squibb Company. DuPont retained
its interest in Cozaar&#174; (losartan potassium) and
Hyzaar&#174; (losartan potassium, hydrochlorothiazide) brands.
These antihypertensive drugs were discovered by DuPont and
developed in collaboration with Merck&nbsp;&#38;&nbsp;Co. Inc.
DuPont has exclusively licensed marketing rights for
Cozaar&#174; and Hyzaar&#174; to Merck and in conjunction with
the sale, Bristol-Myers Squibb has agreed to continue to
manufacture Cozaar&#174; and Hyzaar&#174; for DuPont at the
former DuPont Pharmaceuticals manufacturing site at Garden City,
New York. Effective with the fourth quarter 2001 results, the
Pharmaceuticals segment reflects only DuPont&#146;s share of the
financial results of this onging collaboration.
</FONT>

<P align="left">
<B><FONT size="2">Discontinued Operations</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">On September&nbsp;28, 1998, the company announced
that the Board of Directors had approved a plan to divest the
company&#146;s 100&nbsp;percent-owned petroleum business, Conoco
Inc. On October&nbsp;21, 1998, the company&#146;s interest in
Conoco was reduced to 69.5&nbsp;percent following an initial
public offering of Conoco Class&nbsp;A common stock. On
August&nbsp;6, 1999, the company completed the planned
divestiture through a tax-free split off whereby the company
exchanged its 436,543,573 shares of Conoco Class&nbsp;B common
stock for 147,980,872 shares of DuPont common stock. The
company&#146;s consolidated financial statements and notes
report its former petroleum business as discontinued operations.
</FONT>

<P align="center"><FONT size="2">3
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The following information describing the business
of the company can be found on the indicated pages of
Exhibit&nbsp;13:
</FONT>

<CENTER>
<TABLE width="60%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="80%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">Item</FONT></B></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">Page(s)</FONT></B></TD>
</TR>

<TR>
	<TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
	<TD colspan="3" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Segment Reviews:
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Business Discussions, Principal Products and
	Principal Markets
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Introduction
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">17-18</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Agriculture &#38; Nutrition
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">18-20</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Nylon
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">20-21</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Performance Coatings &#38; Polymers
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">21-22</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Pharmaceuticals
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">22-23</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Pigments &#38; Chemicals
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">23-24</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Polyester
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">24-25</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Specialty Fibers
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">25-27</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Specialty Polymers
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">27-29</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Total Segment Sales, Intersegment Transfers,
	After-Tax Operating Income, and Segment
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Net Assets for 2001, 2000, and 1999
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">71-74</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="3" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Geographic Information:
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Net Sales and Net Property 2001, 2000, and 1999
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">71</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<P align="left">
<B><FONT size="2">Sources of Supply</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company utilizes numerous firms as well as
internal sources to supply a wide range of raw materials,
energy, supplies, services and equipment. To assure
availability, the company maintains multiple sources for fuels
and most raw materials, including hydrocarbon feedstocks. Large
volume purchases are generally procured under competitively
priced supply contracts.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Excluding Pioneer Hi-Bred International Inc. and
the Nutrition &#38; Health businesses, which are part of the
Agriculture &#38; Nutrition segment, a substantial portion of
the production and sales in the segments&#146; businesses is
dependent upon the availability of hydrocarbon feedstocks.
Current hydrocarbon feedstock requirements are met by purchases
from major petrochemical companies. DuPont participates in a
joint venture with Equistar Chemicals, LP, which manufactures
and supplies a significant portion of the company&#146;s
requirements for ethylene glycol, a hydrocarbon feedstock.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Pioneer, which is in the hybrid seed industry,
has seed production facilities located throughout the world, in
both the Northern and Southern Hemispheres. In the production of
its parent and commercial seed, Pioneer generally provides the
seed stock, detasseling and roguing labor, and certain other
production inputs. The balance of the labor, equipment, and
inputs are supplied by independent growers. Pioneer believes the
availability of growers, parent seed stock, and other inputs
necessary to produce its commercial seed is adequate for planned
production levels. The principal risk in the production of seed
is the environment, with weather being the single largest
variant. Pioneer lessens this risk by distributing production
across many locations around the world. Due to its global
presence, the company can engage in seed production year-round.
Production in the Nutrition &#38; Health businesses is primarily
dependent upon the availability of soy flake, which is readily
available from many sources.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The major purchased commodities, raw materials,
and supplies for the company&#146;s reportable segments in 2001
that manufacture products are listed below:
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Agriculture
&#38; Nutrition:</I></FONT></B>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="3%"></TD>
	<TD width="97%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="left">
	<FONT size="2">acetaldoxime; carbamic acid, (3-((dimethylamino)
	carbonyl)-2-pyridinyl-sulfonyl-phenyl ester; carbamic acid,
	(chlorocarbonyl) [4-(trifluoromethoxy) phenyl]-, methylester;
	cyanamide; dichlorophenol isocyanate; methyl mercaptan; soy
	flake; 5-choroindanone, methylester
	</FONT></TD>
</TR>

</TABLE>

<P align="center"><FONT size="2">4
</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Nylon:</I></FONT></B>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="3%"></TD>
	<TD width="97%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="left">
	<FONT size="2">adipic acid; ammonia; butadiene; cyclohexane;
	natural gas
	</FONT></TD>
</TR>

</TABLE>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Performance
Coatings &#38; Polymers:</I></FONT></B>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="3%"></TD>
	<TD width="97%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="left">
	<FONT size="2">adipic acid; butadiene; caustic soda; chlorine;
	cyclohexane; ethylene; fiberglass; hydrocarbon solvents;
	isocyanate resins; melamine resins; methanol; pigments;
	polyethylene; propylene; ultra violet light stabilizer
	</FONT></TD>
</TR>

</TABLE>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Pigments
&#38; Chemicals:</I></FONT></B>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="3%"></TD>
	<TD width="97%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="left">
	<FONT size="2">ammonia; benzene; caustic soda; chlorine; coke;
	methanol; propylene; sodium hydroxide; titanium ore
	</FONT></TD>
</TR>

</TABLE>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Polyester:</I></FONT></B>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="3%"></TD>
	<TD width="97%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="left">
	<FONT size="2">acetic acid; dimethyl terephthalate; ethylene
	glycol; paraxylene; terephthalic acid
	</FONT></TD>
</TR>

</TABLE>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Specialty
Fibers:</I></FONT></B>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="3%"></TD>
	<TD width="97%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="left">
	<FONT size="2">acetylene; high density polyethylene;
	isophthaloyl chloride; metaphenylenediamine;
	paraphenylenediamine; polyester; terephthaloyl chloride; wood
	pulp
	</FONT></TD>
</TR>

</TABLE>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Specialty
Polymers:</I></FONT></B>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="3%"></TD>
	<TD width="97%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="left">
	<FONT size="2">acetic acid; alumina trihydrate; ethane;
	methacrylic acid; polyethylene; natural gas; block co-polymers;
	oxydianiline; 4G7 plasticizer
	</FONT></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In addition, during 2001, the company consumed
substantial amounts of electricity and natural gas for energy.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">DuPont has contracted with Computer Sciences
Corporation (CSC) and Accenture LLP to provide certain services
for the company. CSC operates a majority of DuPont&#146;s global
information systems and technology infrastructures and provides
selected applications and software services. Accenture LLP
provides information systems solutions designed to enhance
DuPont&#146;s manufacturing, marketing, distribution and
customer service.
</FONT>

<P align="left">
<B><FONT size="2">Patents and Trademarks</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company believes that its patent and
trademark estate provides it with an important competitive
advantage and has established a global network of attorneys and
licensing professionals to procure, maintain and protect its
estate.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company owns and is licensed under various
patents, which expire from time to time, covering many products,
processes and product uses. These patents protect many aspects
of the company&#146;s significant research program and the
proprietary goods and services it sells. The actual protection
afforded by these patents varies from country to country and
depends upon the scope of coverage of each individual patent as
well as the availability of legal remedies in each country. The
company owns over 20,000 worldwide patents and over 14,000
worldwide patent applications. In 2001, the company was granted
almost 500 U.S. patents and over 1,800 international patents.
The company&#146;s rights under its patents and licenses, as
well as the products made and sold under them, are important to
the company as a whole and, to varying degrees, important to
each reportable segment.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The U.S. patents covering Cozaar&#174; (losartan
potassium) and Hyzaar&#174; (losartan potassium,
hydrochlorothiazide) compounds, pharmaceutical formulation and
methods for use for treatment of hypertension expire in 2009.
The company has exclusively licensed marketing rights for the
Cozaar&#174; and Hyzaar&#174; brands to Merck&nbsp;&#38; Co.
Inc. as part of its collaborative effort with Merck on the
development of these products. In October 2001, DuPont
Pharmaceuticals was sold to the Bristol-Myers Squibb Company.
</FONT>

<P align="center"><FONT size="2">5
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV align="left">
<FONT size="2">However, DuPont retained its interests in
Cozaar&#174; and Hyzaar&#174;. Effective with fourth quarter
2001 results, the Pharmaceuticals segment reflects only the
financial results of the licensing agreement and the ongoing
collaborative effort with Merck.
</FONT>
</DIV>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The environment in which Pioneer and the rest of
the companies within the seed industry compete is increasingly
affected by new patents, patent positions, patent lawsuits and
the status of various intellectual property rights. Ownership of
and access to intellectual property rights, particularly those
relating to biotechnology, are important to the Pioneer business
and its competitors. No single patent owned by Pioneer is
vitally important to its business. However, Pioneer&#146;s
ability to compete in the future may be affected by its
competitors&#146; intellectual rights, especially those relating
to genetically engineered crops, particularly if those rights
withstand legal challenges, and competitors do not offer
licenses on commercially reasonable terms. See the Agriculture
&#38; Nutrition segment review on pages&nbsp;13-14 of this
report and as incorporated by reference on page&nbsp;4 of this
report to pages&nbsp;18 to&nbsp;20 of Exhibit&nbsp;13.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company has over 2,100 unique trademarks for
its products and services and has over 23,000 worldwide
registrations and applications for these trademarks. Ownership
rights in trademarks do not expire if the trademarks are
continued in use and properly protected. The company has a
number of trademarks that have significant recognition at the
consumer retail level, including DuPont<SUP>TM</SUP> and the
DuPont Oval; Lycra&#174; brand premium stretch fibers;
Stainmaster&#174; carpets; Teflon&#174; fluoropolymers, films,
fabric protectors, fibers, and dispersions; Corian&#174;
surfaces; Cordura&#174; nylon; Coolmax&#174; fibers;
Tactel&#174; nylon; Tyvek&#174; and Kevlar&#174; brands
protective material; and Pioneer&#174; brand seeds. The company
is actively pursuing licensing opportunities for selected
trademarks. For example, the Teflon&#174; trademark has been
extended through brand licensing to personal care products,
automotive car care products, automotive wiper blades, eye glass
lenses and home care products.
</FONT>

<P align="left">
<B><FONT size="2">Seasonality</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Sales of the company&#146;s products in the
Agriculture&nbsp;&#38; Nutrition and the Performance
Coatings&nbsp;&#38; Polymers segments and, to a certain extent,
the Nylon segment, are affected by seasonality. The
Agriculture&nbsp;&#38; Nutrition segment performance is
strongest in the first half of the year. Pioneer generally
operates at a loss during the third and fourth quarters of the
year, and due to the seasonal nature of the seed business,
Pioneer&#146;s inventory is at its highest level at the end of
the calendar year and is sold down in the first and second
quarters. Trade receivables in the Agriculture&nbsp;&#38;
Nutrition segment are at a low point at year-end and increase
through the selling season to peak at the end of the second
quarter. Performance Coatings &#38; Polymers sales reflect
seasonal patterns related to motor vehicle builds and
after-market refinishing, and Nylon&#146;s flooring businesses
are somewhat affected by the seasonality of the construction
industry, which experiences its highest level of activity during
the summer months.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In general, businesses in the remaining segments
are not materially affected by seasonal factors.
</FONT>

<P align="left">
<B><FONT size="2">Marketing</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">With the exception of the Pioneer business, most
products are marketed primarily through DuPont&#146;s sales
force, although in some regions, more emphasis is placed on
sales through distributors. In North America, the majority of
Pioneer&#174; brand seed is marketed through independent sales
representatives. In areas outside the traditional corn belt,
seed products are often marketed through dealers and
distributors who handle other agricultural supplies. Pioneer
products are marketed outside North America through a network of
subsidiaries, joint ventures, and independent
producer-distributors.
</FONT>

<P align="left">
<B><FONT size="2">Major Customers</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company&#146;s sales are not materially
dependent on a single customer or small group of customers. The
Nylon, Polyester, and Performance Coatings&nbsp;&#38; Polymers
segments, however, have several large customers in their
respective industries that are important to these segments&#146;
operating results.
</FONT>

<P align="center"><FONT size="2">6
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="left">
<B><FONT size="2">Competition</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Businesses in DuPont&#146;s eight reportable
segments compete on a variety of factors such as price, product
quality or specifications, continuity of supply, customer
service and breadth of product line, depending on the
characteristics of the particular market involved.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Principal competitors for all segments include
major chemical companies based in the United States, Europe and
Asia, principally Japan, China and Korea. Competitors offer a
comparable range of products from agricultural, commodity and
specialty chemicals to plastics and fibers products. The company
also competes in certain product markets with smaller, more
specialized firms and with petrochemical operations in
oil-producing countries.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In addition to providing crop protection
chemicals, the Agriculture&nbsp;&#38; Nutrition segment also
sells hybrid seeds through Pioneer, principally for the global
production of corn and soybeans, and thus directly competes with
other hybrid seed suppliers. Agriculture&nbsp;&#38; Nutrition
also provides soy-based food ingredients and food safety
equipment in competition with other major grain and food
processors.
</FONT>

<P align="left">
<B><FONT size="2">Research and Development</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company conducts research in the United
States at over 40&nbsp;sites in 18&nbsp;states at either
dedicated research facilities or manufacturing plants. The
highest concentration of research is carried out at several of
the company&#146;s large research centers in and around
Wilmington, Delaware. Among these, the Experimental Station
laboratories engage in exploratory and applied research, the
Chestnut Run laboratories focus on applications research, and
the Stine-Haskell Research Center conducts agricultural product
research and toxicological research on company products to
assure they are safe for manufacture and use. In addition,
Pioneer carries out research and development to develop hybrids
of corn, sorghum and sunflower, and varieties of soybean,
alfalfa, wheat, and canola for worldwide markets. Pioneer
operates more than 90 primary research locations, with its
largest center in Johnston, Iowa. Hybrids and varieties are
developed at these primary research locations and tested at
thousands of other locations.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">DuPont also operates a number of research
facilities at locations outside the United&nbsp;States in
countries such as Belgium, Canada, France, Germany, Japan,
Luxembourg, Mexico, the Netherlands, Spain, Switzerland and the
United Kingdom, reflecting the company&#146;s global interests.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The objectives of the company&#146;s research and
development programs are to discover new products, processes and
business opportunities in relevant fields and to improve
existing products and processes. Each strategic business unit of
the company funds research and development activities to support
its business mission.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The central research laboratories are responsible
for assuring that leading-edge science and engineering concepts
are identified and diffused throughout the DuPont technical
community. All research and development activities are
coordinated by senior research and development management
through a corporate technology council to ensure that technical
activities are consistent with business and corporate plans, and
that the core technical competencies underlying DuPont&#146;s
current and future businesses remain healthy and continue to
provide competitive advantages.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Annual research and development expense and such
expense shown &#147;As Percent of Sales&#148; for the five years
1997 through 2001 are included under the heading
&#147;General&#148; of the Five-Year Financial Review on
page&nbsp;77 of Exhibit&nbsp;13.
</FONT>

<P align="left">
<B><FONT size="2">Environmental Matters</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Information relating to environmental matters is
included in two areas of Exhibit&nbsp;13:
(1)&nbsp;&#147;Management&#146;s Discussion and Analysis&#148;
on pages&nbsp;38-40, and (2)&nbsp;Notes&nbsp;1 and&nbsp;25 to
the financial statements on pages&nbsp;47-50 and 62-63,
respectively.
</FONT>

<P align="center"><FONT size="2">7
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="left">
<B><FONT size="2">Cautionary Statements Under The Private
Securities Litigation Reform Act of 1995</FONT></B>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Forward-Looking
Statements</I></FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">This report contains forward-looking statements
which may be identified by their use of words like
&#147;plans,&#148; &#147;expects,&#148; &#147;will,&#148;
&#147;anticipates,&#148; &#147;intends,&#148;
&#147;projects,&#148; &#147;estimates&#148; or other words of
similar meaning. All statements that address expectations or
projections about the future, including statements about the
company&#146;s strategy for growth, product development, market
position, expenditures and financial results, are
forward-looking statements.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Forward-looking statements are based on certain
assumptions and expectations of future events. The company
cannot guarantee that these assumptions and expectations are
accurate or will be realized. In addition to the factors
discussed in this report and in Management&#146;s Discussion and
Analysis in the company&#146;s latest Annual Report, the
following are some of the important factors that could cause the
company&#146;s actual results to differ materially from those
projected in any such forward-looking statements:
</FONT>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="3%"></TD>
	<TD width="4%"></TD>
	<TD width="93%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD><FONT size="2"> &#149;</FONT></TD>
	<TD align="left">
	<FONT size="2">The company operates in approximately
	75&nbsp;countries worldwide and derives about half of its
	revenues from sales inside the United&nbsp;States and about half
	from sales outside the United&nbsp;States. Therefore,
	governmental and quasi-governmental activities, including
	changes in the laws or policies of any country in which the
	company operates, could affect the company&#146;s business and
	profitability in that country. Also, the company&#146;s business
	and profitability in a particular country could be affected by
	political or economic repercussions on a domestic, country
	specific or global level from terrorist activities and the
	response to such activities. In addition, economic factors
	(including a decline in U.S. or European sales from slowing
	economic growth in those regions, inflation or fluctuations in
	interest and foreign currency exchange rates) and competitive
	factors (such as greater price competition or expiration of
	patent protection) in those countries could affect the
	company&#146;s revenues, expenses and results of operations.
	</FONT></TD>
</TR>

<TR>
	<TD>&nbsp;</TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD><FONT size="2"> &#149;</FONT></TD>
	<TD align="left">
	<FONT size="2">The company&#146;s ability to grow earnings will
	be affected by increases in the cost of raw materials,
	particularly oil, natural gas and products derived from oil and
	natural gas. The company may not be able to fully offset the
	effects of higher raw material costs through price increases or
	productivity improvements.
	</FONT></TD>
</TR>

<TR>
	<TD>&nbsp;</TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD><FONT size="2"> &#149;</FONT></TD>
	<TD align="left">
	<FONT size="2">The company&#146;s growth objectives are largely
	dependent on its ability to renew its pipeline of new products
	and to bring those products to market. This ability may be
	adversely affected by difficulties or delays in product
	development such as the inability to: identify viable new
	products; successfully complete research and development; obtain
	relevant regulatory approvals; obtain adequate intellectual
	property protection; or gain market acceptance of the new
	products.
	</FONT></TD>
</TR>

<TR>
	<TD>&nbsp;</TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD><FONT size="2"> &#149;</FONT></TD>
	<TD align="left">
	<FONT size="2">As part of its strategy for growth, the company
	has made and may continue to make acquisitions and divestitures
	and form strategic alliances. There can be no assurance that
	these will be completed or beneficial to the company.
	</FONT></TD>
</TR>

<TR>
	<TD>&nbsp;</TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD><FONT size="2"> &#149;</FONT></TD>
	<TD align="left">
	<FONT size="2">To a significant degree, results in the
	company&#146;s Agriculture&nbsp;&#38; Nutrition segment reflect
	changes in agricultural conditions, including weather and
	government programs. These results also reflect the seasonality
	of sales of agricultural products; highest sales in the United
	States occur in the first half of the year. In addition, demand
	for products produced in these segments may be affected by
	market acceptance of genetically enhanced products.
	</FONT></TD>
</TR>

<TR>
	<TD>&nbsp;</TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD><FONT size="2"> &#149;</FONT></TD>
	<TD align="left">
	<FONT size="2">The company has undertaken and may continue to
	undertake productivity initiatives, including organizational
	restructurings and Six Sigma productivity improvement projects,
	to improve performance and generate cost savings. There can be
	no assurance that these will be completed or beneficial to the
	company. Also there can be no assurance that any estimated cost
	savings from such activities will be realized.
	</FONT></TD>
</TR>

<TR>
	<TD>&nbsp;</TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD><FONT size="2"> &#149;</FONT></TD>
	<TD align="left">
	<FONT size="2">The company&#146;s facilities are subject to a
	broad array of environmental laws and regulations. The costs of
	complying with complex environmental laws and regulations, as
	well as internal voluntary programs, are significant and will
	continue to be so for the foreseeable future. The company&#146;s
	accruals
	</FONT></TD>
</TR>

</TABLE>

<P align="center"><FONT size="2">8
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="3%"></TD>
	<TD width="2%"></TD>
	<TD width="95%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD></TD>
	<TD align="left">
	<FONT size="2">for such costs and liabilities may not be
	adequate since the estimates on which the accruals are based
	depend on a number of factors including the nature of the
	allegation, the complexity of the site, the nature of the
	remedy, the outcome of discussions with regulatory agencies and
	other potentially responsible parties (PRPs) at multiparty
	sites, and the number and financial viability of other PRPs.
	</FONT></TD>
</TR>

</TABLE>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="3%"></TD>
	<TD width="4%"></TD>
	<TD width="93%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD><FONT size="2"> &#149;</FONT></TD>
	<TD align="left">
	<FONT size="2">The company&#146;s results of operations could be
	affected by significant litigation adverse to the company
	including product liability claims, patent infringement claims
	and antitrust claims.
	</FONT></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The foregoing list of important factors is not
inclusive, or necessarily in order of importance.
</FONT>

<!-- link2 "Item 2. PROPERTIES" -->
<DIV align="left"><A NAME="002"></A></DIV>

<P align="left">
<B><FONT size="2">Item&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PROPERTIES</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company owns and operates manufacturing,
processing, production, marketing, and research and development
facilities worldwide.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">DuPont&#146;s corporate headquarters is located
in Wilmington, Delaware. In addition, the company operates sales
offices, regional purchasing offices, distribution centers, and
various other specialized service locations.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Further information regarding properties is
included in Exhibit&nbsp;13 in the Segment Reviews on
pages&nbsp;17-29. Information regarding research and development
facilities is incorporated by reference to Item&nbsp;1,
Business&nbsp;&#150; Research and Development on page&nbsp;7 of
this report. Additional information with respect to the
company&#146;s property, plant and equipment, and leases is
contained in Notes&nbsp;15 and&nbsp;25 to the company&#146;s
consolidated financial statements on pages&nbsp;59 and 62-63,
respectively, in Exhibit&nbsp;13.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company&#146;s investment in property, plant
and equipment in the United States and Puerto Rico related to
operations is located at some 80&nbsp;sites, the principal of
which are as follows:
</FONT>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="26%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="24%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="21%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="20%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD align="center" nowrap><B><FONT size="1">Texas</FONT></B></TD>
	<TD></TD>
	<TD align="center" nowrap><B><FONT size="1">Delaware</FONT></B></TD>
	<TD></TD>
	<TD align="center" nowrap><B><FONT size="1">Virginia</FONT></B></TD>
	<TD></TD>
	<TD align="center" nowrap><B><FONT size="1">West Virginia</FONT></B></TD>
</TR>

<TR>
	<TD align="center" nowrap><HR size="1" noshade></TD>
	<TD></TD>
	<TD align="center" nowrap><HR size="1" noshade></TD>
	<TD></TD>
	<TD align="center" nowrap><HR size="1" noshade></TD>
	<TD></TD>
	<TD align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
	<TD align="left" valign="top">
	<FONT size="2">Bayport<BR>
	Beaumont<BR>
	Corpus Christi<BR>
	LaPorte<BR>
	Orange<BR>
	Victoria
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Edge Moor<BR>
	Newark<BR>
	Seaford<BR>
	Wilmington
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Front Royal<BR>
	Hopewell<BR>
	Richmond<BR>
	Waynesboro
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Belle<BR>
	Martinsburg<BR>
	Parkersburg
	</FONT></TD>
</TR>

</TABLE>
</CENTER>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="26%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="24%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="21%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="20%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD align="center" nowrap><B><FONT size="1">Tennessee</FONT></B></TD>
	<TD></TD>
	<TD align="center" nowrap><B><FONT size="1">North Carolina</FONT></B></TD>
	<TD></TD>
	<TD align="center" nowrap><B><FONT size="1">New Jersey</FONT></B></TD>
	<TD></TD>
	<TD align="center" nowrap><B><FONT size="1">South Carolina</FONT></B></TD>
</TR>

<TR>
	<TD align="center" nowrap><HR size="1" noshade></TD>
	<TD></TD>
	<TD align="center" nowrap><HR size="1" noshade></TD>
	<TD></TD>
	<TD align="center" nowrap><HR size="1" noshade></TD>
	<TD></TD>
	<TD align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
	<TD align="left" valign="top">
	<FONT size="2">Chattanooga<BR>
	Memphis<BR>
	New Johnsonville<BR>
	Old Hickory
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Fayetteville<BR>
	Kinston<BR>
	Research<BR>&nbsp;&nbsp;Triangle Park
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Deepwater<BR>
	Parlin
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Camden<BR>
	Charleston<BR>
	Florence
	</FONT></TD>
</TR>

</TABLE>
</CENTER>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="26%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="24%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="21%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="20%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD align="center" nowrap><B><FONT size="1">New York</FONT></B></TD>
	<TD></TD>
	<TD align="center" nowrap><B><FONT size="1">Michigan</FONT></B></TD>
	<TD></TD>
	<TD align="center" nowrap><B><FONT size="1">Iowa</FONT></B></TD>
	<TD></TD>
	<TD align="center" nowrap><B><FONT size="1">Puerto Rico</FONT></B></TD>
</TR>

<TR>
	<TD align="center" nowrap><HR size="1" noshade></TD>
	<TD></TD>
	<TD align="center" nowrap><HR size="1" noshade></TD>
	<TD></TD>
	<TD align="center" nowrap><HR size="1" noshade></TD>
	<TD></TD>
	<TD align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
	<TD align="left" valign="top">
	<FONT size="2">Buffalo<BR>
	Niagara Falls
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Mt. Clemens<BR>
	Troy
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Clinton<BR>
	Fort Madison<BR>
	Johnston
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Manati
	</FONT></TD>
</TR>

</TABLE>
</CENTER>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Property, plant and equipment outside the
United&nbsp;States and Puerto&nbsp;Rico is located at about
100&nbsp;sites, principally in the United&nbsp;Kingdom, Canada,
Germany, the&nbsp;Netherlands, Taiwan, Spain, Singapore,
Luxembourg, France, Mexico, Brazil, Belgium, China, Argentina,
Japan and the Republic of Korea.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company&#146;s plants and equipment are well
maintained and in good operating condition. Sales as a percent
of capacity were 78&nbsp;percent in 2001, 81&nbsp;percent in
2000 and 83&nbsp;percent in 1999. These properties are directly
owned by the company except for some auxiliary facilities and
miscellaneous properties, such as certain buildings and
transportation equipment, which are leased. Although no title
examination of the properties has been made for the purpose of
this report, the company knows of no material defects in title
to any of these properties.
</FONT>

<P align="center"><FONT size="2">9
</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<!-- link2 "Item 3. LEGAL PROCEEDINGS" -->
<DIV align="left"><A NAME="003"></A></DIV>

<P align="left">
<B><FONT size="2">Item&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LEGAL
PROCEEDINGS</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In 1991, DuPont began receiving claims by growers
that use of Benlate&#174; 50&nbsp;DF fungicide had caused crop
damage. DuPont since has been served with several hundred
lawsuits, most of which were disposed of by trial, dismissal or
settlement. Approximately 110 cases are pending. Some of these
lawsuits were filed by growers who allege plant damage from
using Benlate&#174; 50&nbsp;DF and, in some cases,
Benlate&#174;&nbsp;WP. Some include claims for alleged damage to
shrimping operations from Benlate&#174;&nbsp;OD, and a smaller
number of cases include claims for alleged personal injuries.
Also, many of these cases include allegations of fraud and
misconduct, as well as violations of Federal and State
racketeering laws. In August&nbsp;2001, a Florida jury found
DuPont liable under Florida&#146;s racketeering statute and for
product defect involving alleged crop damage. Plaintiffs are
seeking to have judgment entered for about $88.5&nbsp;million.
The court is considering post-trial motions; DuPont will appeal.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In addition, a securities fraud class action was
filed in September&nbsp;1995 by a shareholder in federal
district court in Florida against the company and the
then-Chairman. This action is still pending. The plaintiff in
this case alleges that DuPont made false and misleading
statements and omissions about Benlate&#174; 50 DF, with the
alleged effect of inflating the price of DuPont&#146;s stock
between June&nbsp;19, 1993 and January&nbsp;27, 1995. The
district court has certified the case as a class action, and
discovery is proceeding.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Certain plaintiffs who had previously settled
with the company have filed cases alleging fraud and other
misconduct relating to the litigation and settlement of
Benlate&#174; 50 DF claims. Approximately 47 such cases were
filed. Recently, the Florida Federal Court dismissed the lead
case of 25 cases pending before it. The plaintiffs have
appealed. The remaining cases are in various stages of
development in trial and appellate courts in Florida and Hawaii.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">A shareholder derivative action was filed in
August of 2001 in Florida. The suit alleged that the Board of
Directors breached various duties in connection with the
Benlate&#174; litigation and asserted claims under the Federal
and State racketeering laws. This case has been dismissed by the
plaintiff.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Twenty-eight cases are pending against the
company in State Court in Broward County, Florida. These cases
were brought by Ecuadorian shrimp farmers alleging that
Benlate&#174; OD applied to banana plantations in Ecuador
ran-off and was deposited in plaintiffs&#146; shrimp farms,
causing massive numbers of shrimp to die. Two cases were tried
in the fall of 2000 and in early 2001, and resulted in adverse
judgments of approximately $14&nbsp;million and
$16&nbsp;million, respectively. The company has appealed both
cases. DuPont contends that the injuries alleged are
attributable to a virus, Taura Syndrome Virus, and in no way
involved Benlate&#174; OD. The untried cases are on hold
awaiting resolution by the appellate court of the case tried in
2000.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">DuPont believes that Benlate&#174; did not cause
the damages alleged in these cases and denies the allegations of
fraud and misconduct. DuPont continues to defend itself in
ongoing matters. DuPont discontinued the manufacture and sale of
Benlate&#174; fungicide in all its forms in 2001. The ultimate
liabilities from the Benlate&#174; lawsuits discussed above may
be significant to the company&#146;s results of operations in
the period recognized, but management does not anticipate that
they will have a material adverse effect on the company&#146;s
consolidated financial position or liquidity.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company&#146;s balance sheets reflect
accruals for estimated costs associated with this matter.
Adverse changes in estimates for such liabilities could result
in additional future charges.
</FONT>

<P align="left">
<B><FONT size="2">Environmental Proceedings</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">On May&nbsp;19, 1997, approximately 11,500 pounds
of a hydrogen fluoride (HF)/tar mixture was released from
DuPont&#146;s Louisville, Kentucky, fluoroproducts facility.
This release lasted about forty minutes. There were no on-site
injuries, and only one off-site person reported any exposure. No
toxic tort suits were filed as a result of this release.
DuPont&#146;s incident investigation concluded that an
inadequate valve stem design was a key factor contributing to
the release (the valve stem twisted and the valve indicated it
was in a closed position, when it was actually open).
DuPont&#146;s process isolation procedures were also reviewed
and modified as a result of this incident. The Department of
Justice (DOJ)&nbsp;proposed a settlement prior to filing its
action for $1,700,000. Subsequently, by letter dated
July&nbsp;13, 1999, the DOJ provided formal notice to DuPont,
that
</FONT>

<P align="center"><FONT size="2">10
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV align="left">
<FONT size="2">due to the May&nbsp;1997 HF release, the DOJ
intended to bring a federal court action against DuPont under
the CAA Section&nbsp;112(r)&nbsp;&#150; General Duty Clause.
DuPont contested the proposed $1,700,000 fine as excessive and
unreasonable because there was no environmental harm or human
health impacts associated with the May 1997 incident. DuPont
presented a settlement offer to the DOJ and the Environmental
Protection Agency (EPA) in December 2000. DuPont has recently
reached an agreement with DOJ and EPA to settle this matter for
$1,102,000. This settlement consists of $552,000 in supplemental
environmental projects supporting local Louisville governmental
and nongovernmental environmental agencies and $550,000 as a
cash penalty. The DOJ has prepared a Consent Decree and
Complaint that DuPont is currently reviewing. Settlement is
expected to be completed sometime in the second quarter of 2002.
</FONT>
</DIV>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Indiana Departments of Natural Resources and
Environmental Management and the United States Department of
Interior are in the process of conducting a natural resource
damage assessment of the Grand Calumet River and the Indiana
Harbor Canal system under the Comprehensive Environmental
Response, Compensation and Liability Act (CERCLA) and the Oil
Pollution Act. The company&#146;s plant in East Chicago,
Indiana, which discharges industrial wastewater into these
waterways, was identified as one of seventeen potentially
responsible parties (PRPs) for the cost of the assessment and
any determined natural resource damages. The trustees recently
indicated that their preferred remedy is to dredge the entire
Grand Cal/ Indiana Harbor system. DuPont has joined with eight
other PRPs to contest the remedy. A settlement offer has been
tendered to the trustees and negotiations are ongoing.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">On October&nbsp;31, 2001, the Secretary of the
Department of Natural Resources and Environmental Control (the
Secretary), an administrative agency of the State of Delaware,
filed a complaint alleging that the DuPont Edgemoor facility had
(1)&nbsp;improperly operated storage ponds without a permit,
(2)&nbsp;improperly operated a staging pile with out a permit,
(3)&nbsp;allowed the discharge of an air contaminant without a
permit, and (4)&nbsp;allowed the discharge of a water pollutant
to surface water without a permit. The Secretary sought civil
penalties under 7&nbsp;Del.&nbsp;C.&nbsp;6005(b)(1) for $1,000
to $10,000 per day for each day of violation of counts 2-4 and
under 7&nbsp;Del.&nbsp;C.&nbsp;6309(b) for $1,000 to $25,000 per
day of violation of the other counts. DuPont denied the
allegations but acknowledged that there were environmental
concerns associated with these activities and agreed to cease
and desist and to take appropriate remedial action. Therefore,
concurrent with the filing of the Complaint in the Delaware
Superior Court, the Secretary filed a Consent Order in which the
parties agreed that DuPont will (1)&nbsp;close the surface
impoundments in a manner protective of human health and the
environment, (2)&nbsp;conduct a facility wide Corrective Action,
(3)&nbsp;enter into a voluntary clean-up program to close the
staging pile, (4)&nbsp;investigate and mitigate any impacts to
human health and the environment resulting from offsite uses of
the staging material and (5)&nbsp;submit a payment of $7,000 per
year for oversight expenses during the life of the Consent
Order. The approximate cost of these activities is estimated at
$12,400,000 and reserves were established at December&nbsp;31,
2001 to cover these costs. Since the Consent Order resolves the
Complaint, DuPont is not subject to the civil penalties sought
in the latter.
</FONT>

<!-- link2 "Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS" -->
<DIV align="left"><A NAME="004"></A></DIV>

<P align="left">
<B><FONT size="2">Item&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SUBMISSION
OF MATTERS TO A VOTE OF SECURITY HOLDERS</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">None.
</FONT>

<P align="center"><FONT size="2">11
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="center">
<B>EXECUTIVE OFFICERS OF THE REGISTRANT</B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The following is a list, as of March&nbsp;7,
2002, of the company&#146;s executive officers. These officers
serve as members of the company&#146;s Office of the Chief
Executive.
</FONT>

<CENTER>
<TABLE width="70%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="74%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="6%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="2"></TD>
	<TD></TD>
	<TD colspan="3"></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">Executive</FONT></B></TD>
</TR>

<TR>
	<TD colspan="2"></TD>
	<TD></TD>
	<TD colspan="3"></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">Officer</FONT></B></TD>
</TR>

<TR>
	<TD colspan="2"></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">Age</FONT></B></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">Since</FONT></B></TD>
</TR>

<TR>
	<TD colspan="2"></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Chairman of the Board of Directors and Chief
	Executive Officer:
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Charles O. Holliday, Jr.(1)
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">53</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">1992</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Other Executive Officers:
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Thomas M. Connelly, Senior Vice President and
	Chief Science and Technology Officer
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">49</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">2000</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Richard R. Goodmanson, Executive Vice President
	and Chief Operating Officer
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">54</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">1999</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">John C. Hodgson, Executive Vice President
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">58</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">2002</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Stacey J. Mobley, Senior Vice President and Chief
	Administrative Officer and General Counsel
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">56</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">1992</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Gary M. Pfeiffer, Senior Vice President and Chief
	Financial Officer
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">52</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">1997</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Dennis Zeleny, Senior Vice President&nbsp;&#150;
	Global Human Resources
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">46</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">2001</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<P align="left">
<HR size="1" width="15%" align="left" noshade>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="5%"></TD>
	<TD width="95%"></TD>
</TR>

<TR valign="top">
	<TD><FONT size="2">(1)</FONT></TD>
	<TD align="left">
	<FONT size="2">Member of the Board of Directors.
	</FONT></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company&#146;s executive officers are elected
or appointed for the ensuing year or for an indefinite term, and
until their successors are elected or appointed.
Messrs.&nbsp;Holliday and Mobley have each been employed by
DuPont in executive officer positions for more than the past
five years.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Thomas M. Connelly joined DuPont in 1977 as a
research engineer. Since then, Mr.&nbsp;Connelly has served in
various research and plant technical leadership roles, as well
as product management and business director roles. Prior to his
promotion to Senior Vice President and Chief Science and
Technology Officer, Mr.&nbsp;Connelly served as vice president
and general manager&nbsp;&#150; DuPont Fluoroproducts from 1999
until September&nbsp;1, 2000 when he was named to his current
position.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Richard&nbsp;R. Goodmanson joined DuPont in 1999
as Executive Vice President and Chief Operating Officer. Prior
to joining DuPont, Mr.&nbsp;Goodmanson was president and chief
executive officer of America West Airlines from 1996 to 1999. He
was senior vice president of operations for Frito-Lay Inc. from
1992-1996, and he was a principal at McKinsey &#38; Company,
Inc. from 1980 to 1992.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">John C. Hodgson joined DuPont in 1966. Since
then, Mr.&nbsp;Hodgson has held various sales and product
management positions and has served in several business director
roles. In 1996, he was named vice president and general manager
of Photopolymer &#38; Electronic Materials. Prior to his
promotion to Executive Vice President with responsibility for
the company&#146;s five newly formed growth platforms,
Mr.&nbsp;Hodgson served as group vice president and general
manager&nbsp;&#150; DuPont <I>i</I>Technologies from
February&nbsp;2000 until he was named to his current position in
February&nbsp;2002.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Gary&nbsp;M. Pfeiffer joined the company in 1974
and has held a succession of tax and financial and business
analysis positions. Mr.&nbsp;Pfeiffer has also served in several
director roles and prior to his promotion to Senior Vice
President and Chief Financial Officer, Mr.&nbsp;Pfeiffer served
as vice president and general manager, DuPont Nylon&nbsp;&#150;
North America from 1994 until October&nbsp;1997 when he was
named to his current position.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Dennis Zeleny joined DuPont in 2001 as Senior
Vice President&nbsp;&#150; Global Human Resources. Prior to
joining DuPont, Mr.&nbsp;Zeleny was vice president, Worldwide
Human Resources for Honeywell, a position he held since 2000,
following the merger of Allied Signal with Honeywell. From 1995
to 2000, Mr.&nbsp;Zeleny served as vice president, human
resources in several capacities for Allied Signal, and from 1978
to 1995, Mr.&nbsp;Zeleny held a number of human resources
positions at PepsiCo.
</FONT>

<P align="center"><FONT size="2">12
</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<!-- link1 "PART II" -->
<DIV align="left"><A NAME="005"></A></DIV>

<P align="center">
<B>PART II</B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Information with respect to the following Items
can be found on the indicated pages of Exhibit&nbsp;13 if not
otherwise included herein.
</FONT>

<!-- link2 "Item 5. MARKET FOR REGISTRANT&#146;S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS" -->
<DIV align="left"><A NAME="006"></A></DIV>

<DIV>&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="8%"></TD>
	<TD width="92%"></TD>
</TR>

<TR valign="top">
	<TD><B><FONT size="2">Item&nbsp;5.</FONT></B></TD>
	<TD>
	<B><FONT size="2">MARKET FOR REGISTRANT&#146;S COMMON EQUITY AND
	RELATED STOCKHOLDER MATTERS</FONT></B></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The company&#146;s common stock is listed on the
New York Stock Exchange, Inc. (symbol DD) and certain non-U.S.
exchanges. The number of record holders of common stock was
126,718 at December&nbsp;31, 2001, and 125,473 at March&nbsp;7,
2002.
</FONT>

<CENTER>
<TABLE width="60%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="83%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="2"></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">Page(s)</FONT></B></TD>
</TR>

<TR>
	<TD colspan="2"></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<B><FONT size="2">Quarterly Financial Data:</FONT></B></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Dividends Per Share of Common Stock
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">76</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Market Price of Common Stock (High/Low)
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">76</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<P align="left">
<B><FONT size="2">Item&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SELECTED
FINANCIAL DATA</FONT></B>

<CENTER>
<TABLE width="60%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="86%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="2%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Five-Year Financial Review:
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Summary of Operations
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">77</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Financial Position at Year End
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">77</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">General
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">77</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<DIV>&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="8%"></TD>
	<TD width="92%"></TD>
</TR>

<TR valign="top">
	<TD><B><FONT size="2">Item&nbsp;7.</FONT></B></TD>
	<TD>
	<B><FONT size="2">MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF
	FINANCIAL CONDITION AND RESULTS OF OPERATIONS</FONT></B></TD>
</TR>

</TABLE>

<CENTER>
<TABLE width="60%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="83%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="3" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Management&#146;s Discussion and Analysis:
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Analysis of Continuing Operations
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">14-17</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Discontinued Operations
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">17</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Segment Reviews
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">17-29</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="7"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Further to the Agriculture &#38; Nutrition
	Segment discussion in Exhibit&nbsp;13 on pages&nbsp;18-20:
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="7"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<I><FONT size="2">Glyphosate Tolerant Soybeans</FONT></I></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="7"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">In December&nbsp;1999, the Monsanto Company filed
	suit in the U.S. District Court for the Eastern District of
	Missouri against Pioneer claiming that its merger with DuPont
	breached a 1992 license agreement granting Pioneer the right to
	produce and market Roundup Ready&#174; glyphosate tolerant
	soybeans. Monsanto asked for damages for the breach and
	termination of the license. Monsanto&#146;s complaint also
	alleged claims for patent infringement and trade secret
	misappropriation if the license were terminated. On
	March&nbsp;20, 2001, the court, on motions for summary judgment,
	found that DuPont&#146;s acquisition of Pioneer terminated the
	agreement. The court found no breach of contract and therefore,
	awarded no damages on this claim. It held that any claim for
	damages or other relief Monsanto seeks will have to wait until
	the next phase of the litigation, which involves Monsanto&#146;s
	patent infringement and trade secret allegations.
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<P align="center"><FONT size="2">13
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<CENTER>
<TABLE width="60%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="86%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">The court found that its determination involved
	controlling questions of law as to which there is a substantial
	difference of opinion and that an immediate appeal would advance
	the ultimate determination of this litigation. Those questions
	involve whether federal common law or state merger law should
	control the transferability of patent licenses. The court has
	certified its decision for immediate appeal to the U.S. Court of
	Appeals for the Federal Circuit. Pioneer has filed an appeal.
	The company believes that the appellate court will ultimately
	find that state merger law rather than federal common law
	controls in merger situations and, therefore, that no prohibited
	license transfer took place when DuPont acquired Pioneer. The
	district court has stayed all other proceedings regarding patent
	infringement and trade secret claims pending the outcome of the
	appeal. A favorable decision for Pioneer on appeal will
	reinstate the license and preclude all other claims. The appeal
	was heard on February&nbsp;5, 2002. A decision is not expected
	until later in 2002.
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="6"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">On October&nbsp;1, 1999, the company acquired the
	approximately 80&nbsp;percent of Pioneer not previously owned
	for $7,684 million. An intangible asset has been recorded to
	recognize the value of the 1992 license agreement. Should the
	ultimate outcome of this lawsuit be adverse to the company, the
	value of this intangible asset may become impaired, resulting in
	a one-time noncash charge to earnings.
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="6"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Management does not anticipate that the ultimate
	outcome of this lawsuit will have a material adverse effect on
	the company&#146;s consolidated financial position, liquidity or
	results of operations, although it could be significant to the
	results of operations of the Agriculture &#38; Nutrition segment
	in the period recognized.
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="6"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Liquidity and Capital Resources
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">29-32</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Purchased In-Process Research and Development
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">33-37</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Financial Instruments
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">37-38</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Environmental Matters
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">38-40</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Forward-Looking Statements
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">40-41</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<DIV>&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="9%"></TD>
	<TD width="91%"></TD>
</TR>

<TR valign="top">
	<TD><B><FONT size="2">Item&nbsp;7A.</FONT></B></TD>
	<TD>
	<B><FONT size="2">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT
	MARKET RISK</FONT></B></TD>
</TR>

</TABLE>

<CENTER>
<TABLE width="60%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="83%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="3" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Management&#146;s Discussion and Analysis:
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Financial Instruments
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Derivatives and Other Hedging Instruments
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">37</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Foreign Currency Risk
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">37</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Interest Rate Risk
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">37-38</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Commodity Price Risk
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">38</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Value at Risk
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">38</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<P align="center"><FONT size="2">14
</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV>&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="8%"></TD>
	<TD width="92%"></TD>
</TR>

<TR valign="top">
	<TD><B><FONT size="2">Item 8.</FONT></B></TD>
	<TD>
	<B><FONT size="2">FINANCIAL STATEMENTS AND SUPPLEMENTARY
	DATA</FONT></B></TD>
</TR>

</TABLE>

<CENTER>
<TABLE width="60%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="83%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="2"></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">Page(s)</FONT></B></TD>
</TR>

<TR>
	<TD colspan="2"></TD>
	<TD></TD>
	<TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
	<TD colspan="6"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Financial Statements:
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Report of Independent Accountants
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">42</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Consolidated Income Statement for 2001, 2000, and
	1999
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">43</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Consolidated Balance Sheet as of
	December&nbsp;31, 2001 and December&nbsp;31, 2000
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">44</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Consolidated Statement of Stockholders&#146;
	Equity for 2001, 2000 and 1999
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">45</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Consolidated Statement of Cash Flows for 2001,
	2000 and 1999
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">46</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Notes to Financial Statements
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">47-75</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD colspan="2" align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Quarterly Financial Data and related notes for
	the following items for the quarters in the two years ended
	December&nbsp;31, 2001 and 2000:
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Sales
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">76</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Cost of goods sold and other expenses
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">76</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Income before cumulative effect of a change in
	accounting principle
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">76</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Net income (loss)
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">76</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Basic earnings (loss)&nbsp;per share of common
	stock before cumulative effect of a change in accounting
	principle
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">76</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Basic earnings (loss)&nbsp;per share of common
	stock
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">76</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Diluted earnings (loss)&nbsp;per share of common
	stock before cumulative effect of a change in accounting
	principle
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">76</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Diluted earnings (loss)&nbsp;per share of common
	stock
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">76</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Dividends per share of common stock
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">76</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Market price of common stock
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">76</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<DIV>&nbsp;</DIV>

<!-- link2 "Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE" -->
<DIV align="left"><A NAME="007"></A></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="8%"></TD>
	<TD width="92%"></TD>
</TR>

<TR valign="top">
	<TD><B><FONT size="2">Item&nbsp;9.</FONT></B></TD>
	<TD>
	<B><FONT size="2">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
	ON ACCOUNTING AND FINANCIAL DISCLOSURE</FONT></B></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">None.
</FONT>

<DIV>&nbsp;</DIV>

<!-- link1 "PART III" -->
<DIV align="left"><A NAME="008"></A></DIV>

<DIV align="center">
<B>PART III</B>
</DIV>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Information with respect to the following Items
is incorporated by reference to the pages indicated in the
company&#146;s 2001 Annual Meeting Proxy Statement dated
March&nbsp;21, 2002, filed in connection with the Annual Meeting
of Stockholders to be held April&nbsp;24, 2002. However,
information regarding executive officers is contained in
Part&nbsp;I of this report (page&nbsp;12) pursuant to General
Instruction&nbsp;G of this form.
</FONT>

<DIV>&nbsp;</DIV>

<!-- link2 "Item 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT" -->
<DIV align="left"><A NAME="009"></A></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="9%"></TD>
	<TD width="91%"></TD>
</TR>

<TR valign="top">
	<TD><B><FONT size="2">Item&nbsp;10.</FONT></B></TD>
	<TD>
	<B><FONT size="2">DIRECTORS AND EXECUTIVE OFFICERS OF THE
	REGISTRANT</FONT></B></TD>
</TR>

</TABLE>

<CENTER>
<TABLE width="60%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="89%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Election of Directors
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">8-11</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Compliance With the Securities Exchange Act
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">13</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<DIV>&nbsp;</DIV>

<!-- link2 "Item 11. EXECUTIVE COMPENSATION" -->
<DIV align="left"><A NAME="010"></A></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="9%"></TD>
	<TD width="91%"></TD>
</TR>

<TR valign="top">
	<TD><B><FONT size="2">Item&nbsp;11.</FONT></B></TD>
	<TD>
	<B><FONT size="2">EXECUTIVE COMPENSATION</FONT></B></TD>
</TR>

</TABLE>

<CENTER>
<TABLE width="60%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="89%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Compensation of Directors
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">6-7</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Compensation and Stock Option Information
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">17-19</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Retirement Benefits
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">21</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<DIV>&nbsp;</DIV>

<!-- link2 "Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT" -->
<DIV align="left"><A NAME="011"></A></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="9%"></TD>
	<TD width="91%"></TD>
</TR>

<TR valign="top">
	<TD><B><FONT size="2">Item&nbsp;12.</FONT></B></TD>
	<TD>
	<B><FONT size="2">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
	OWNERS AND MANAGEMENT</FONT></B></TD>
</TR>

</TABLE>

<CENTER>
<TABLE width="60%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="89%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Beneficial Ownership of Securities
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">11-13</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<DIV>&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="9%"></TD>
	<TD width="91%"></TD>
</TR>

<TR valign="top">
	<TD><B><FONT size="2">Item&nbsp;13.</FONT></B></TD>
	<TD>
	<B><FONT size="2">CERTAIN RELATIONSHIPS AND RELATED
	TRANSACTIONS</FONT></B></TD>
</TR>

</TABLE>

<CENTER>
<TABLE width="60%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="89%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR><TD><TR><TD><TR><TD><TR><TD>

<TR>
	<TD align="left" valign="top">
	<DIV style="margin-left:10px; text-indent:-10px">
	<FONT size="2">Election of Directors
	</FONT></DIV>
	</TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="bottom" nowrap><FONT size="2">8-11</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<P align="center"><FONT size="2">15
</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="center">
<B>PART IV</B>

<!-- link2 "Item 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K" -->
<DIV align="left"><A NAME="012"></A></DIV>

<DIV>&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
        <TD width="9%"></TD>
        <TD width="91%"></TD>
</TR>

<TR valign="top">
        <TD><B><FONT size="2">Item&nbsp;14.</FONT></B></TD>
        <TD>
        <B><FONT size="2">EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND
        REPORTS ON FORM 8-K</FONT></B></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">(a)&nbsp;Financial Statements, Financial
Statement Schedules and Exhibits:
</FONT>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
        <TD width="3%"></TD>
        <TD width="97%"></TD>
</TR>

<TR valign="top">
        <TD>&nbsp;</TD>
        <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        <FONT size="2">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial
        Statements. (See listing at Part II, Item 8 of this report
        regarding financial statements, which are incorporated by
        reference to Exhibit&nbsp;13.)
        </FONT></TD>
</TR>

<TR>
        <TD>&nbsp;</TD>
</TR>

<TR valign="top">
        <TD>&nbsp;</TD>
        <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        <FONT size="2">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial
        Statement Schedules&nbsp;&#150; none required.
        </FONT></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The following should be read in conjunction with
the previously referenced Financial Statements:
</FONT>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
        <TD width="3%"></TD>
        <TD width="97%"></TD>
</TR>

<TR valign="top">
        <TD>&nbsp;</TD>
        <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        <FONT size="2">Financial Statement Schedules listed under SEC
        rules but not included in this report are omitted because they
        are not applicable or the required information is shown in the
        consolidated financial statements or notes thereto incorporated
        by reference.
        </FONT></TD>
</TR>

<TR>
        <TD>&nbsp;</TD>
</TR>

<TR valign="top">
        <TD>&nbsp;</TD>
        <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        <FONT size="2">Condensed financial information of the parent
        company is omitted because restricted net assets of consolidated
        subsidiaries do not exceed 25&nbsp;percent of consolidated net
        assets. Footnote disclosure of restrictions on the ability of
        subsidiaries and affiliates to transfer funds is omitted because
        the restricted net assets of subsidiaries combined with the
        company&#146;s equity in the undistributed earnings of
        affiliated companies does not exceed 25&nbsp;percent of
        consolidated net assets at December&nbsp;31, 2001.
        </FONT></TD>
</TR>

<TR>
        <TD>&nbsp;</TD>
</TR>

<TR valign="top">
        <TD>&nbsp;</TD>
        <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        <FONT size="2">Separate financial statements of affiliated
        companies accounted for by the equity method are omitted because
        no such affiliate individually constitutes a 20&nbsp;percent
        significant subsidiary.
        </FONT></TD>
</TR>

<TR>
        <TD>&nbsp;</TD>
</TR>

<TR valign="top">
        <TD>&nbsp;</TD>
        <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        <FONT size="2">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits
        </FONT></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The following list of exhibits includes both
exhibits submitted with this Form&nbsp;10-K as filed with the
SEC and those incorporated by reference to other filings:
</FONT>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
        <TD width="6%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="6%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="84%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
        <TD colspan="3" align="center" nowrap><B><FONT size="1">Exhibit</FONT></B></TD>
        <TD></TD>
        <TD></TD>
</TR>

<TR>
        <TD colspan="3" align="center" nowrap><B><FONT size="1">Number</FONT></B></TD>
        <TD></TD>
        <TD align="center" nowrap><B><FONT size="1">Description</FONT></B></TD>
</TR>

<TR>
        <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
        <TD></TD>
        <TD align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right" valign="top" nowrap><FONT size="2">3.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top">
        <FONT size="2">Company&#146;s Restated Certificate of
        Incorporation, filed May&nbsp;29, 1997 (incorporated by
        reference to the company&#146;s filing on Form&nbsp;8-K on
        June&nbsp;13, 1997).
        </FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right" valign="top" nowrap><FONT size="2">3.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top">
        <FONT size="2">Company&#146;s Bylaws, as last revised
        January&nbsp;1, 1999 (incorporated by reference to
        Exhibit&nbsp;3.2 of the company&#146;s Annual Report on
        Form&nbsp;10-K for the year ended December&nbsp;31, 1998).
        </FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right" valign="top" nowrap><FONT size="2">4</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top">
        <FONT size="2">The company agrees to provide the Commission, on
        request, copies of instruments defining the rights of holders of
        long-term debt of the company and its subsidiaries.
        </FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right" valign="top" nowrap><FONT size="2">10.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top">
        <FONT size="2">The DuPont Stock Accumulation and Deferred
        Compensation Plan, as last amended April&nbsp;29, 1998
        (incorporated by reference to Exhibit&nbsp;10.3 of the
        company&#146;s Quarterly Report on Form&nbsp;10-Q for the period
        ended March&nbsp;31, 1998).
        </FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right" valign="top" nowrap><FONT size="2">10.3</FONT></TD>
        <TD align="left" valign="top" nowrap><FONT size="2">*</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top">
        <FONT size="2">Company&#146;s Supplemental Retirement Income
        Plan, as last amended effective June&nbsp;4, 1996.
        </FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right" valign="top" nowrap><FONT size="2">10.4</FONT></TD>
        <TD align="left" valign="top" nowrap><FONT size="2">*</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top">
        <FONT size="2">Company&#146;s Pension Restoration Plan, as last
        amended effective June&nbsp;4, 1996.
        </FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right" valign="top" nowrap><FONT size="2">10.5</FONT></TD>
        <TD align="left" valign="top" nowrap><FONT size="2">*</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top">
        <FONT size="2">Company&#146;s Stock Performance Plan, as last
        amended effective January&nbsp;28, 1998 (incorporated by
        reference to Exhibit&nbsp;10.1 of the company&#146;s Quarterly
        Report on Form&nbsp;10-Q for the period ended March&nbsp;31,
        1998).
        </FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right" valign="top" nowrap><FONT size="2">10.6</FONT></TD>
        <TD align="left" valign="top" nowrap><FONT size="2">*</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top">
        <FONT size="2">Company&#146;s Variable Compensation Plan, as
        last amended effective April&nbsp;30, 1997 (incorporated by
        reference to pages&nbsp;A1-A3 of the company&#146;s Annual
        Meeting Proxy Statement dated March&nbsp;21, 2002).
        </FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right" valign="top" nowrap><FONT size="2">10.7</FONT></TD>
        <TD align="left" valign="top" nowrap><FONT size="2">*</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top">
        <FONT size="2">Company&#146;s Salary Deferral &#38; Savings
        Restoration Plan effective April&nbsp;26, 1994, as last amended
        effective January&nbsp;1, 2000 (incorporated by reference to
        Exhibit&nbsp;10.7 of the company&#146;s Quarterly Report on
        Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2001).
        </FONT></TD>
</TR>

</TABLE>
</CENTER>

<DIV align="left">

</DIV>

<P align="left">
<HR size="1" width="25%" align="left" noshade>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
        <TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="86%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD colspan="5" align="right" valign="top">
        <FONT size="2">*&nbsp;&nbsp;Management contract or compensatory
        plan or arrangement required to be filed as an exhibit to this
        Form&nbsp;10-K.
        </FONT></TD>
</TR>

</TABLE>
</CENTER>

<DIV align="left">

</DIV>

<P align="center"><FONT size="2">16
</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="6%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="6%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="84%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">Exhibit</FONT></B></TD>
	<TD></TD>
	<TD></TD>
</TR>

<TR>
	<TD colspan="3" align="center" nowrap><B><FONT size="1">Number</FONT></B></TD>
	<TD></TD>
	<TD align="center" nowrap><B><FONT size="1">Description</FONT></B></TD>
</TR>

<TR>
	<TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
	<TD></TD>
	<TD align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="top" nowrap><FONT size="2">10.8</FONT></TD>
	<TD align="left" valign="top" nowrap><FONT size="2">*</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Company&#146;s 1995 Corporate Sharing Plan,
	adopted by the Board of Directors on January&nbsp;25, 1995
	(incorporated by reference to Exhibit&nbsp;10.8 of the
	company&#146;s Annual Report on Form&nbsp;10-K for the year
	ended December&nbsp;31, 1999).
	</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="top" nowrap><FONT size="2">10.9</FONT></TD>
	<TD align="left" valign="top" nowrap><FONT size="2">*</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Company&#146;s 1997 Corporate Sharing Plan,
	adopted by the Board of Directors on January&nbsp;29, 1997.
	</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="top" nowrap><FONT size="2">10.10</FONT></TD>
	<TD align="left" valign="top" nowrap><FONT size="2">*</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Company&#146;s Retirement Income Plan for
	Directors, as last amended August&nbsp;1995 (incorporated by
	reference to Exhibit&nbsp;10.12 of the company&#146;s Quarterly
	Report on Form&nbsp;10-Q for the quarter ended March&nbsp;31,
	1997).
	</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="top" nowrap><FONT size="2">10.11</FONT></TD>
	<TD align="left" valign="top" nowrap><FONT size="2">*</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Letter Agreement and Employee Agreement, dated as
	of April&nbsp;22, 1999, between this company and
	R.R.&nbsp;Goodmanson (incorporated by reference to
	Exhibit&nbsp;10.11 of the company&#146;s Annual Report on
	Form&nbsp;10-K for the year ended December&nbsp;31, 1999).
	</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="top" nowrap><FONT size="2">10.13</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Company&#146;s Purchase Agreement dated
	June&nbsp;7, 2001, by and among the company DuPont Pharma, Inc.,
	DuPont Pharmaceuticals Company, DuPont Electronic Materials,
	Inc., DuPont Diagnostics, Inc., and Bristol-Myers Squibb Company
	(incorporated by reference to Exhibit&nbsp;10.13 of the
	company&#146;s Quarterly Report on Form&nbsp;10-Q for the
	quarter ended June&nbsp;30, 2001).
	</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="top" nowrap><FONT size="2">10.14</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Amendment to Purchase Agreement, dated as of
	October&nbsp;1, 2001, to the Purchase Agreement, dated
	June&nbsp;7, 2001, by and among E.I.&nbsp;du&nbsp;Pont
	de&nbsp;Nemours and Company, DuPont Pharma, Inc., DuPont
	Pharmaceuticals Company, DuPont Electronic Materials, Inc.,
	DuPont Diagnostics, Inc., and Bristol- Myers Squibb Company
	(incorporated by reference to Exhibit&nbsp;10.14 of the
	company&#146;s Quarterly Report on Form&nbsp;10-Q for the
	quarter ended September&nbsp;30, 2001).
	</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="top" nowrap><FONT size="2">11</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Statement re calculation of earnings per share.
	</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="top" nowrap><FONT size="2">12</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Statement re computation of the ratio of earnings
	to fixed charges.
	</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="top" nowrap><FONT size="2">13</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Management&#146;s Discussion and Analysis and
	Financial Information Section of the Annual Report to
	Shareholders for the year ended December&nbsp;31, 2001, which
	are furnished to the Commission for information only, and not
	filed except as expressly incorporated by reference in this
	Report.
	</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="top" nowrap><FONT size="2">21</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Subsidiaries of the Registrant.
	</FONT></TD>
</TR>

<TR>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="right" valign="top" nowrap><FONT size="2">23</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left" valign="top">
	<FONT size="2">Consent of Independent Accountants.
	</FONT></TD>
</TR>

</TABLE>
</CENTER>

<P align="left">
<HR size="1" width="18%" align="left" noshade>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="4%"></TD>
	<TD width="96%"></TD>
</TR>

<TR valign="top">
	<TD><FONT size="2">*</FONT></TD>
	<TD align="left">
	<FONT size="2">Management contract or compensatory plan or
	arrangement required to be filed as an exhibit to this
	Form&nbsp;10-K.
	</FONT></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">(b)&nbsp;Reports on Form&nbsp;8-K:
</FONT>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="3%"></TD>
	<TD width="97%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
	<FONT size="2">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
	October&nbsp;24, 2001, a Current report on Form&nbsp;8-K,
	pursuant to Regulation&nbsp;FD, was filed in connection with
	Debt and/or Equity Securities that may be offered on a delayed
	or continuous basis under its Registration Statements on
	Form&nbsp;S-3 (No.&nbsp;33-53327, No.&nbsp;33-61339, No.
	33-60069, and No.&nbsp;333-86363). Under Item&nbsp;5,
	&#147;Other Events,&#148; the Registrant filed a news release
	entitled &#147;DuPont Reports Third Quarter 2001 Earnings.&#148;
	</FONT></TD>
</TR>

<TR>
	<TD>&nbsp;</TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
	<FONT size="2">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
	January&nbsp;23, 2002, a Current Report on Form&nbsp;8-K,
	pursuant to Regulation&nbsp;FD, was filed in connection with
	Debt and/or Equity Securities that may be offered on a delayed
	or continuous basis under its Registration Statements on
	Form&nbsp;S-3 (No.&nbsp;33-53327, No.&nbsp;33-61339,
	No.&nbsp;33-60069 and No.&nbsp;333-86363). Under Item&nbsp;5,
	&#147;Other Events,&#148; the Registrant filed a news release
	entitled &#147;DuPont Reports Fourth Quarter And Full-Year 2001
	Earnings.&#148;
	</FONT></TD>
</TR>

<TR>
	<TD>&nbsp;</TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
	<FONT size="2">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
	February&nbsp;11, 2002, a Current Report on Form&nbsp;8-K was
	filed in connection with Debt and/or Equity Securities that may
	be offered on a delayed or continuous basis under its
	Registration Statements on Form&nbsp;S-3 (No.&nbsp;33-53327,
	No.&nbsp;33-61339, No.&nbsp;33-60069 and No.&nbsp;333-86363).
	Under Item 5, &#147;Other Events,&#148; the Registrant filed a
	news release entitled &#147;DuPont Aligns Businesses By Markets,
	Technologies; Forms Textiles&nbsp;&#38; Interiors
	Subsidiary.&#148;
	</FONT></TD>
</TR>

</TABLE>

<P align="center"><FONT size="2">17
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="013"></A></DIV>

<P align="center">
<B><FONT size="2">SIGNATURES</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">Pursuant to the requirements of
Section&nbsp;13 of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized and in the
capacities indicated, as of the 21st&nbsp;day of
March&nbsp;2002.</FONT></B>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="38%"></TD>
	<TD width="62%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="left">
	<FONT size="2">E. I. DU PONT DE NEMOURS AND COMPANY
	</FONT></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="center">
	<FONT size="2">(Registrant)
	</FONT></TD>
</TR>

</TABLE>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="38%"></TD>
	<TD width="2%"></TD>
	<TD width="60%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD><FONT size="2">By:&nbsp;</FONT></TD>
	<TD align="center">
	<FONT size="2">/s/G. M. PFEIFFER
	</FONT></TD>
</TR>

</TABLE>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
	<TD width="38%"></TD>
	<TD width="62%"></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="left">
	<HR size="1" align="left" noshade></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="center">
	<B><FONT size="2">G. M. Pfeiffer</FONT></B></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="center">
	<B><FONT size="2">Senior Vice President and</FONT></B></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="center">
	<B><FONT size="2">Chief Financial Officer</FONT></B></TD>
</TR>

<TR valign="top">
	<TD>&nbsp;</TD>
	<TD align="center">
	<B><FONT size="2">(Principal Financial and Accounting
	Officer)</FONT></B></TD>
</TR>

</TABLE>

<P align="center">
<HR size="1" width="30%" align="center" noshade>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">Pursuant to the requirements of the Securities
Exchange Act of 1934, this report has been signed as of the
21st&nbsp;day of March&nbsp;2002 by the following persons on
behalf of the registrant in the capacities indicated:</FONT></B>

<P align="center">
<B><FONT size="2">Chairman of the Board and Chief Executive
Officer</FONT></B>

<DIV align="center">
<B><FONT size="2">and Director:</FONT></B>
</DIV>

<DIV align="center">
<B><FONT size="2">(Principal Executive Officer):</FONT></B>
</DIV>

<P align="center">
<FONT size="2">/s/ C. O. HOLLIDAY, JR.
</FONT>

<DIV align="center">
<HR size="1" width="41%" align="center" noshade><B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B>
</DIV>

<DIV align="center">
<B><FONT size="2">C. O. Holliday, Jr.</FONT></B>
</DIV>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">Directors:</FONT></B>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
	<TD width="51%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
	<TD width="46%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD align="center" valign="top">
	<FONT size="2">/s/ A. J. P. BELDA
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">/s/ L. D. JULIBER</FONT></B></TD>
</TR>

<TR>
	<TD align="left"><HR size="1" noshade></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left"><HR size="1" noshade></TD>

</TR>

<TR>
	<TD align="center" valign="top">
	<B><FONT size="2">A. J. P. Belda</FONT></B></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">L. D. Juliber</FONT></B></TD>
</TR>

<TR>
	<TD colspan="3"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD align="center" valign="top">
	<FONT size="2">/s/ R. H. BROWN
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">/s/ G. LINDAHL</FONT></B></TD>
</TR>

<TR>
	<TD align="left"><HR size="1" noshade></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left"><HR size="1" noshade></TD>

</TR>

<TR>
	<TD align="center" valign="top">
	<B><FONT size="2">R. H. Brown</FONT></B></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">G. Lindahl</FONT></B></TD>
</TR>

<TR>
	<TD colspan="3"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD align="center" valign="top">
	<FONT size="2">/s/ C. J. CRAWFORD
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">/s/ M. NAITOH</FONT></B></TD>
</TR>

<TR>
	<TD align="left"><HR size="1" noshade></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left"><HR size="1" noshade></TD>

</TR>

<TR>
	<TD align="center" valign="top">
	<B><FONT size="2">C. J. Crawford</FONT></B></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">M. Naitoh</FONT></B></TD>
</TR>

<TR>
	<TD colspan="3"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD align="center" valign="top">
	<FONT size="2">/s/ L. C. DUEMLING
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">/s/ W. K. REILLY</FONT></B></TD>
</TR>

<TR>
	<TD align="left"><HR size="1" noshade></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left"><HR size="1" noshade></TD>

</TR>

<TR>
	<TD align="center" valign="top">
	<B><FONT size="2">L. C. Duemling</FONT></B></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">W. K. Reilly</FONT></B></TD>
</TR>

<TR>
	<TD colspan="3"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD align="center" valign="top">
	<FONT size="2">/s/ E. B. DU PONT
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">/s/ H. R. SHARP, III</FONT></B></TD>
</TR>

<TR>
	<TD align="left"><HR size="1" noshade></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left"><HR size="1" noshade></TD>

</TR>

<TR>
	<TD align="center" valign="top">
	<B><FONT size="2">E. B. du Pont</FONT></B></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">H. R. Sharp, III</FONT></B></TD>
</TR>

<TR>
	<TD colspan="3"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
	<TD align="center" valign="top">
	<FONT size="2">/s/ D. C. HOPKINS
	</FONT></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">/s/ C. M. VEST</FONT></B></TD>
</TR>

<TR>
	<TD align="left"><HR size="1" noshade></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="left"><HR size="1" noshade></TD>

</TR>

<TR>
	<TD align="center" valign="top">
	<B><FONT size="2">D. C. Hopkins</FONT></B></TD>
	<TD><FONT size="2">&nbsp;</FONT></TD>
	<TD align="center" valign="top">
	<B><FONT size="2">C. M. Vest</FONT></B></TD>
</TR>

</TABLE>
</CENTER>

<P align="center"><FONT size="2">18
</FONT>
</BODY>
</HTML>

</TEXT>
</DOCUMENT>
